安杰思收盘上涨1.31%，滚动市盈率17.23倍，总市值51.16亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Anjiasi Medical Technology Co., Ltd., which operates in the medical device industry, specifically focusing on minimally invasive endoscopic diagnostic and therapeutic instruments [1][2] - As of June 24, Anjiasi's closing price was 63.18 yuan, reflecting a 1.31% increase, with a rolling price-to-earnings (PE) ratio of 17.23 times and a total market capitalization of 5.116 billion yuan [1] - The average PE ratio for the medical device industry is 49.12 times, with a median of 36.07 times, positioning Anjiasi at the 41st rank within the industry [1][2] Group 2 - As of the first quarter of 2025, 11 institutions held shares in Anjiasi, including 6 funds and 5 other entities, with a total holding of 17.7325 million shares valued at 1.26 billion yuan [1] - Anjiasi's main products include GI series, EMR/ESD series, ERCP diagnostic series, and therapeutic instruments, contributing to its revenue growth [1] - The latest financial report for the first quarter of 2025 shows Anjiasi achieved an operating income of 129 million yuan, a year-on-year increase of 15.27%, and a net profit of 56.2483 million yuan, reflecting a year-on-year growth of 6.57%, with a gross profit margin of 70.68% [1]